Uxin (UXIN) had the highest return between July 1, 2022 and July 7, 2022 by a small-cap US stock or small-cap US stock, returning 90%.
| ASSET | DATE | % RETURN |
|---|---|---|
Uxin (UXIN) | 7/1/2022 - 7/7/2022 | 89.98% |
Avadel Pharmaceuticals (AVDL) | 7/1/2022 - 7/7/2022 | 73.47% |
Tyra Biosciences (TYRA) | 7/1/2022 - 7/7/2022 | 49.64% |
Accolade (ACCD) | 7/1/2022 - 7/7/2022 | 49.54% |
Omeros (OMER) | 7/1/2022 - 7/7/2022 | 41.07% |
Novavax (NVAX) | 7/1/2022 - 7/7/2022 | 40.3% |
Dianthus Therapeutics (DNTH) | 7/1/2022 - 7/7/2022 | 39.34% |
GeneDx (WGS) | 7/1/2022 - 7/7/2022 | 39.17% |
Trevi Therapeutics (TRVI) | 7/1/2022 - 7/7/2022 | 35.84% |
Ginkgo Bioworks (DNA) | 7/1/2022 - 7/7/2022 | 35.28% |
Adaptive Biotechnologies (ADPT) | 7/1/2022 - 7/7/2022 | 32.96% |
Relay Therapeutics (RLAY) | 7/1/2022 - 7/7/2022 | 32.28% |
Terawulf (WULF) | 7/1/2022 - 7/7/2022 | 29.75% |
Verve Therapeutics (VERV) | 7/1/2022 - 7/7/2022 | 29.59% |
Sana Biotechnology (SANA) | 7/1/2022 - 7/7/2022 | 29.55% |
BioLife Solutions (BLFS) | 7/1/2022 - 7/7/2022 | 28.02% |
Dyne Therapeutics (DYN) | 7/1/2022 - 7/7/2022 | 27.91% |
Eos Energy Enterprises (EOSE) | 7/1/2022 - 7/7/2022 | 27.87% |
GCM Grosvenor (GCMGW) | 7/1/2022 - 7/7/2022 | 27.81% |
Geron (GERN) | 7/1/2022 - 7/7/2022 | 27.1% |
D-MARKET Electronic Services & Trading ADR (HEPS) | 7/1/2022 - 7/7/2022 | 26.13% |
Teladoc (TDOC) | 7/1/2022 - 7/7/2022 | 25.88% |
Nerdy (NRDY) | 7/1/2022 - 7/7/2022 | 25.6% |
Blend Labs (BLND) | 7/1/2022 - 7/7/2022 | 25.53% |
Nuvation Bio (NUVB) | 7/1/2022 - 7/7/2022 | 25.47% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
